Brooklyn Capital Management »

Drugs Made In Amer Acqutn shares owned by Brooklyn Capital Management

Quarter-by-quarter ownership of Drugs Made In Amer Acqutn (DMAAR) shares owned by Brooklyn Capital Management from 13F filings

Historical chart of Brooklyn Capital Management investment in Drugs Made In Amer Acqutn

Tip: Access up to 7 years of quarterly data

All positions including Drugs Made In Amer Acqutn held by Brooklyn Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Drugs Made In Amer Acqutn by Brooklyn Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $28k 130k 0.22
2025-06-30 $8.8k 73k 0.12

More positions owned by Brooklyn Capital Management

General American Investors (GAM)
Boulder Growth & Income Fund (STEW)
Central Securities (CET)
Neuberger Berman Next Genera Common Stock (NBXG)
Bny Mellon Strategic Municipal Bond Fund closed end income funds non-taxable (DSM)
Cion Invt Corp (CION)
Tejon Ranch Company (TRC)
Runway Growth Finance Corp (RWAY)
Mfs High Yield Mun Tr Sh Ben Int (CMU)
AllianceBernstein Natnl Muncpl Incm Fnd. (AFB)
Cannae Holdings (CNNE)
Texas Pacific Land Corp (TPL)
Gabelli Dividend & Income Trust (GDV)
Mfs Invt Grade Mun Tr Sh Ben Int (CXH)
Oxford Lane Cap Corp

View all positions for Brooklyn Capital Management

Top funds holding Drugs Made In Amer Acqutn

Polar Securities
Hudson Bay Capital Management
Harraden Circle Investments
Toronto-Dominion Bank
Highbridge Capital Management
Aristeia Capital
Mangrove Partners
Linden Advisors
Clear Street
Glazer Capital
Shaolin Capital Management
Atw Spac Management
Boothbay Fund Management
Wolverine Asset Management
Westchester Capital Management

View all funds holding Drugs Made In Amer Acqutn